Represented JATT Acquisition Corp., a special purpose acquisition company, in its $165 million business combination with Zura Bio, a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorder.
-
资深顾问律师
-
副主席兼纽约办公室管理合伙人;资本市场及公司业务部联席主席;亚洲业务部主席”; 纽约,北京
-
合伙人